MedlinePlus , a service of the National Library of Medicine, lists nausea, diarrhea, vomiting, constipation, stomach pain, and decreased appetite among the effects patients may notice
This medication is especially helpful for adults with diabetes or migraines
The key is knowing where to look and how to avoid shady operators
Following publication of a technology appraisal publication by the National Institute for Health and Care Excellence (NICE) in December 2024 [3], Tirzepatide has been approved as a novel agent for weight loss management within the NHS (NICE, 2025)
It is not intended for dry-eye relief
Step therapy creates additional barriers by forcing patients to attempt older medications like metformin or phentermine before tirzepatide is considered